Home › NDC Lookup › Ingredients › Camphor Menthol Methyl Salicylate › 85713-0101-01
DRMITSUI Pain Relieving Patch Camphor Menthol Methyl salicylate 3.1 g/100g; 6 g/100g; 10 g/100g Patch — NDC 85713-0101-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

DRMITSUI Pain Relieving Patch Camphor Menthol Methyl salicylate 3.1 g/100g; 6 g/100g; 10 g/100g Patch — NDC 85713-101-01 (Billing 85713-0101-01)

by Guangzhou Ruyu Cosmetics Co., Ltd · 6 PATCH in 1 BOX / 10 g in 1 PATCH

This is a package of DRMITSUI Pain Relieving Patch Camphor Menthol Methyl salicylate 3.1 g/100g; 6 g/100g; 10 g/100g Patch from Guangzhou Ruyu Cosmetics Co., Ltd, no longer marketed (first marketed Dec 2025), no longer in the FDA NDC Directory. It is this product's only package size.

NDC 85713-0101-01
🏷️ FDA NDC (as labeled) 85713-101-01 billing pads the product segment with a zero
OTC Discontinued Non-controlled ⚠ Inactivated by FDA ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 85713-101-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
85713 labeler · 101 product · 01 package
Package marketed since
Dec 16, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 8571310101 6
FDA record last changed
Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory. FDA inactivated this product’s listing record, so it is excluded from the active NDC Directory. The listing was last certified through Dec 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 85713-101-01
Product NDC 85713-101
11-digit billing NDC 85713010101
UNII L7T10EIP3A, 213N3S8275, LAV5U5022Y
Application # M017
SPL Set ID 460c376c-3026-2460-e063-6394a90a0089
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Inactivated by FDA (certified through Dec 2026)
Marketing start 2025-12-16
Route TOPICAL
Dosage form PATCH
Substance MENTHOL; CAMPHOR, (-)-; METHYL SALICYLATE
Why two NDCs? The FDA registers this code as 85713-101-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 85713-0101-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

DRMITSUI Pain Relieving Patch is a topical patch containing camphor, menthol, and methyl salicylate. This is an over-the-counter monograph drug, meaning it is marketed under FDA's established guidelines for topical pain-relieving products rather than as an individually reviewed application. Camphor, menthol, and methyl salicylate are commonly used in topical patches to produce a warming or cooling sensation and are typically included to help relieve minor muscle and joint aches. The patch is applied directly to the skin over the affected area.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
85713-0101-01 You're viewing this Main listing 6 PATCH in 1 BOX / 10 g in 1 PATCH 2025-12-16 — Inactivated by FDA

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
DRMITSUI Pain Relieving Patch 3.1 g/100g; 6 g/100g; 10 g/100gthis 85713-0101-01 Guangzhou 6 patches — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Dec 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII T1FAD4SS2M
    Aluminum silicate is a mineral compound used as a thickener, absorbent, and anti-caking agent in medicines. It helps give liquid or powder formulations the right texture and prevents clumping.
  • UNII T5L8T28FGP
    Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.
  • UNII TQ77WR8A02
    A synthetic rubber polymer used as a binder and film-former in medicines. It helps hold tablet ingredients together and can create a protective coating or matrix that controls how quickly the drug releases in the body.
  • UNII K7S96QM8DV
    A synthetic rubber-like plastic made from linked chains of styrene and isoprene. It's used in medicines as a binder to hold ingredients together and as a film-former to create protective coatings on tablets or capsules.
  • UNII GR35AH6YDN
    A sticky plant-derived resin containing terpenes, natural compounds from trees and plants. Used as a binder and adhesive in some tablet and capsule formulations to help hold ingredients together.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesMINERAL OIL, PERFUME,POLYISOBUTYLENE, STYRENE-ISOPRENE-STYRENE BLOCK COPOLYMER. SYNTHETIC ALUMINUM SILICATE,TERPENE RESIN, TITANIUM DIOXIDE.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGuangzhou Ruyu Cosmetics Co., Ltd
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code85713
First marketedDec 2025
Product typeHuman Otc Drug
Portfolio2 products on file

More NDCs from Guangzhou Ruyu Cosmetics Co., Ltd labeler code 85713

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 43 words ▾

DIRECTIONS Adults and children 12 years of age and over:1. Clean and dry affected area. 2. Remove patch from film. 3. Apply to affected areas not morethan 3 to 4 times daily. 4. Remove patch from the skin after at most 8-hour application.

⏱️ Dosage and Administration 21 words ▾

Apply to affected areas not morethan 3 to 4 times daily. Remove patch from the skin after at most 8-hour application.

⚠️ Warnings 108 words ▾

1.For external use only. 2.Allergy alert: lf prone to allergic reaction from aspirin or salicylates, consult a doctor before use3.Do not use: On wounds or damaged skin. With a heating pad. lf you are allergic to anyingredients of this product.

4.When using this product: Use only as directed. Avoid contact with the eyes. mucousmembranes or rashes. Do not bandage tightly 5.Stop using it and ask a doctor if: Skin reactions such as redness, itching, rash, excessiveirritation, burning sensation,swelling or blistering occur.

Conditions worsen.Symptomspersist for more than 7 days. Symptoms clear up and occur again within a few days6.Pregnancy/breast-feeding warning: lf pregnant or breast-feeding, ask a healthprofessional before use.

🧪 Active Ingredient 12 words ▾

ACTIVEINGREDIENTS PURPOSE CamphorMenthol 3.1% Topical analgesicTopical analgesicTopical analgesic 6.0% Methyl salicylate 10.0%

🧪 Inactive Ingredients 12 words ▾

MINERAL OIL, PERFUME,POLYISOBUTYLENE, STYRENE-ISOPRENE-STYRENE BLOCK COPOLYMER. SYNTHETIC ALUMINUM SILICATE,TERPENE RESIN, TITANIUM DIOXIDE.

🎯 Purpose 19 words ▾

For temporary relief of minor aches & pains of muscles & joints associated with:Arthritis, Simple backache, Strains, Bruises, Sprains

📄 Keep Out of Reach of Children 6 words ▾

Keep out of children to reach

📄 Package Label / Principal Display Panel 1 words ▾

labeling

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Camphor Menthol Methyl salicylate — the ingredient across all brands.

Top reported reactions

Application Site Burn6
Application Site Pain6
Chemical Injury4
Erythema3
Malaise3
Pain3
Rash3

Age at onset

Adult1

Reporter sex

49 reports
Male · 34%
Female · 66%

Serious outcomes

Hospitalization9
Life-threatening1
Disabling1
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 4 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Guangzhou Ruyu Cosmetics Co., Ltd is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 85712-0212-45 · BLISS 85713-0102-01 · Guangzhou →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.